Novo Nordisk Plunges 20% YTD: How Should Investors Play the Stock?

• click to rate

  Posted by Two Blokes Jul 15 - Filed in Stock - 1 view
  
  NVO shares fall 19.9% year to date amid weak CagriSema data, CEO exit and rising pressure from rivals in obesity care.